Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Couch

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Vaccine|July 8, 2008
Seasonal inactivated influenza virus vaccinesRobert B Couch
Journal of Health Care Finance|November 3, 2011
Financing development stage biotechnology companies: RMs vs. IPOsMark J Ahn, Robert B Couch, Wei Wu
Respiratory Research|June 29, 2007
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytesInnocent N Mbawuike, Yongxin Zhang, Robert B Couch
Plos One|December 15, 2012
A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccineRobert B Couch, Shital M Patel, Chianti L Wade-Bowers, et al.
The Journal of Infectious Diseases|August 30, 2008
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variantsWendy A Keitel, Robert L Atmar, Diane Nino, et al.
Virology Journal|December 8, 2006
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2JingQi Feng, Manxin Zhang, Krystyna Mozdzanowska, et al.
Vaccine|June 15, 2007
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adultsRobert L Atmar, Wendy A Keitel, Thomas R Cate, et al.
Vaccine|October 31, 2012
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccinesRobert B Couch, Robert L Atmar, Wendy A Keitel, et al.
Journal of Clinical Microbiology|November 26, 2011
Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illnessRobert L Atmar, Pedro A Piedra, Shital M Patel, et al.
The Journal of Infectious Diseases|January 28, 2004
Dose-dependent neutralizing-antibody responses to vacciniaRobert B Belshe, Frances K Newman, Sharon E Frey, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Vaccine|July 8, 2008
Seasonal inactivated influenza virus vaccinesRobert B Couch
Journal of Health Care Finance|November 3, 2011
Financing development stage biotechnology companies: RMs vs. IPOsMark J Ahn, Robert B Couch, Wei Wu
Respiratory Research|June 29, 2007
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytesInnocent N Mbawuike, Yongxin Zhang, Robert B Couch
Plos One|December 15, 2012
A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccineRobert B Couch, Shital M Patel, Chianti L Wade-Bowers, et al.
The Journal of Infectious Diseases|August 30, 2008
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variantsWendy A Keitel, Robert L Atmar, Diane Nino, et al.
Virology Journal|December 8, 2006
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2JingQi Feng, Manxin Zhang, Krystyna Mozdzanowska, et al.
Vaccine|June 15, 2007
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adultsRobert L Atmar, Wendy A Keitel, Thomas R Cate, et al.
Vaccine|October 31, 2012
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccinesRobert B Couch, Robert L Atmar, Wendy A Keitel, et al.
Journal of Clinical Microbiology|November 26, 2011
Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illnessRobert L Atmar, Pedro A Piedra, Shital M Patel, et al.
The Journal of Infectious Diseases|January 28, 2004
Dose-dependent neutralizing-antibody responses to vacciniaRobert B Belshe, Frances K Newman, Sharon E Frey, et al.
Pageof 4